Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum

Swansea University, UK.
BMC Cancer (Impact Factor: 3.32). 11/2010; 10:640. DOI: 10.1186/1471-2407-10-640
Source: PubMed

ABSTRACT Survival time for lung cancer is poor with over 90% of patients dying within five years of diagnosis primarily due to detection at late stage. The main objective of this study was to evaluate Fourier transform infrared spectroscopy (FTIR) as a high throughput and cost effective method for identifying biochemical changes in sputum as biomarkers for detection of lung cancer.
Sputum was collected from 25 lung cancer patients in the Medlung observational study and 25 healthy controls. FTIR spectra were generated from sputum cell pellets using infrared wavenumbers within the 1800 to 950 cm-1 "fingerprint" region.
A panel of 92 infrared wavenumbers had absorbances significantly different between cancer and normal sputum spectra and were associated with putative changes in protein, nucleic acid and glycogen levels in tumours. Five prominent significant wavenumbers at 964 cm-1, 1024 cm-1, 1411 cm-1, 1577 cm-1 and 1656 cm-1 separated cancer spectra from normal spectra into two distinct groups using multivariate analysis (group 1: 100% cancer cases; group 2: 92% normal cases). Principal components analysis revealed that these wavenumbers were also able to distinguish lung cancer patients who had previously been diagnosed with breast cancer. No patterns of spectra groupings were associated with inflammation or other diseases of the airways.
Our results suggest that FTIR applied to sputum might have high sensitivity and specificity in diagnosing lung cancer with potential as a non-invasive, cost-effective and high-throughput method for screening. NCT00899262.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Colon cancer is associated with a high incidence and a poor prognosis. The aim of the present study was to determine whether Fourier transform infrared (FTIR) microspectroscopy can be used to monitor the chemotherapy drug‑induced apoptosis of SW620 colon cancer cells. The 50% inhibitory concentration (IC50) of 5‑fluorouracil (5‑FU), the main chemotherapeutic agent used for the treatment of colorectal cancer, was determined as the inhibition of growth of the SW620 cells using an MTT assay. Cell starvation and 5‑FU treatment synergized to arrest the cells in the G1 and S phases of the cell cycle. FTIR combined with fluorescence activated cell sorting (FACS) analysis were used to analyze the SW620 cells following treatment with 5‑FU for 12, 24 and 48 h. The apoptotic cells had several spectral characteristics. The relative peak intensity ratio (I1740/I1460) was significantly increased (P<0.05), the I1740/I1460 ratio, associated with a band of amino acid residues at 1,410 cm‑1 was significantly increased at the early and late phases of cell death (P<0.05), the peaks at 1,240 cm‑1 increased in wave number, a band at 1,040 cm‑1, associated with polysaccharides, appeared at 24 and 48 h and then moved to a higher wave number and the I1040/I1460 ratio increased at the late stage of apoptosis. These results demonstrated that FTIR can be used as a label‑free technique to monitor cancer cell apoptosis and to understand the spectral fingerprints of apoptotic cells. This suggested that FTIR spectral features have potential as a powerful tool to monitor cancer cell apoptosis.
    Molecular Medicine Reports 12/2014; 11(4). DOI:10.3892/mmr.2014.3088 · 1.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This review provides a brief background to the application of infrared spectroscopy, including Fourier transform-infrared spectroscopy, in biological fluids. It is not meant to be complete or exhaustive but to provide the reader with sufficient background for selected applications in cancer diagnostics. Fourier transform-infrared spectroscopy (FT-IR) is a fast and nondestructive analytical method. The infrared spectrum of a mixture serves as the basis to quantitate its constituents, and a number of common clinical chemistry tests have proven to be feasible using this approach. This review focuses on biomedical FT-IR applications, published in the period 2009–2013, used for early detection of cancer through qualitative and quantitative analysis.
    Critical Reviews in Analytical Chemistry 04/2015; 45(2). DOI:10.1080/10408347.2014.904733 · 2.69 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The vibrational spectroscopy techniques of Raman spectroscopy and Fourier-transform infrared spectroscopy offer a number of potential advantages as tools for clinical diagnosis. The ability of these methods to detect subtle biochemical changes relating to pathology opens the possibility of their use in tissue diagnosis. Potential applications include use as an 'optical biopsy' technique for in vivo tissue diagnosis or to guide therapy, as a 'digital staining' method to assist a histopathologist in analysing a sample, or as an entirely automated process for histopathology classification. To date, much work has been undertaken in applying these spectroscopic methods to discriminate between disease states across a wide range of pathologies and organ systems, but as yet none have entered routine clinical practice. There is a pressing clinical need for real-time, accurate tissue diagnosis, especially in malignant conditions for which rapid diagnosis and comprehensive identification and treatment of diseased tissue are of paramount importance. Cancer diagnostics remains reliant on analysis of tissue samples by histopathologists to confirm malignancy, based on morphological tissue changes and immunohistochemical staining techniques. There is increasing evidence that vibrational spectroscopy, in combination with chemometric data analysis, is a powerful and accurate technique for detecting cancerous and pre-cancerous biochemical changes both in vitro and in vivo, for a range of malignant conditions. This review examines the progress of vibrational spectroscopy towards selected clinical applications, with a particular focus on cancer diagnostics.
    Analytical methods 01/2014; 6(12-12):3901-3917. DOI:10.1039/c3ay42235f · 1.94 Impact Factor

Full-text (5 Sources)

Available from
May 27, 2014